Water Island Capital’s Albany Molecular Research Inc AMRI Stock Holding History

Water Island Capital’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,085,000	Closed	-$23.5M	–	145
2017 Q2	$23.5M	Buy	+1,085,000	New	+$19.7M	1.11%	21

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Water Island Capital's AMRI Position: Q3 2017 in Review

Water Island Capital sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 1,085,000 shares — an estimated $23.5M sold.

Water Island Capital first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $23.5M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

Water Island Capital reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
Water Island Capital sold 1,085,000 Albany Molecular Research Inc shares in Q3 2017, an estimated $23.5M.
Water Island Capital first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
Water Island Capital's Albany Molecular Research Inc position peaked at $23.5M in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Water Island Capital's 13F filing for Q3 2017, filed 14 Nov 2017.